Breast Cancer Clinical Trial

Caloric Restriction Before Surgery in Treating Patients With Endometrial, Prostate, or Breast Cancer

Summary

The purpose of this trial is to determine that sort term calorie restriction will affect tumor biology in biopsy proven breast, endometrial or prostate cancers, which will positively impact biomarkers including miR-21, an onco-miR known to impact cancer outcomes.

View Full Description

Full Description

PRIMARY OBJECTIVES:

1) Investigate if caloric restriction will change serum micro ribonucleic acid (RNA) 21 (miR-21) expression in patients with prostate, endometrial or breast cancer.

SECONDARY OBJECTIVES:

Investigate measurable changes induced by caloric restriction on both patient (host) and tumor characteristics from caloric restriction.
Investigate the adherence of the patient to the diet.

4) Weight, height, and body composition will be assessed via BodyMetrix. BodyMetrix uses ultrasound technology to measure subcutaneous fat.

5) Patients will have psycho-social evaluation using the Functional Assessment of Cancer Therapy-Prostate (FACT-P) test (prostate cancer), FACT-Breast (B) test (breast cancer), or the FACT-Endometrial Cancer (En) test (endometrial cancer) and the Patient Reported Outcomes Measurement Information System (PROMIS) cancer fatigue short form at baseline, midway through diet, and at the conclusion of the diet.

6) Patient's nutritional status (Mini Nutritional Assessment [MNA] form) will be assessed, and their caloric needs will be calculated.

7) Local recurrence, progression free survival, distant metastases and overall survival will be assessed.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Histological documentation of cancer of the endometrium, prostate or breast.
Candidate for definitive cancer surgery as determined by treating physician
The ability for the definitive cancer surgery to be scheduled within 4-12 weeks post initiation of dietary intervention as determined by the enrolling physician (not from diagnosis - but from start of diet).
No other malignancy within the past 6 months unless it was a non-melanomatous skin lesion
BMI ≥21
ECOG Performance Status of 2 or less
Patient must not be on anti-retrovirals since they may alter patient metabolism

Exclusion Criteria:

Patient is not a candidate for definitive cancer surgery
Definitive cancer surgery can not be performed within 4-12 weeks post study enrollment as determined by the enrolling physician.
Body Mass Index < 21
Another malignancy within the past 6 months that was not a non-melanomatous skin lesion
ECOG Performance Status >2
Patient on anti-retrovirals since they may alter patient metabolism

Study is for people with:

Breast Cancer

Estimated Enrollment:

49

Study ID:

NCT02983279

Recruitment Status:

Active, not recruiting

Sponsor:

Sidney Kimmel Cancer Center at Thomas Jefferson University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Thomas Jefferson University
Philadelphia Pennsylvania, 19107, United States

How clear is this clinincal trial information?

Study is for people with:

Breast Cancer

Estimated Enrollment:

49

Study ID:

NCT02983279

Recruitment Status:

Active, not recruiting

Sponsor:


Sidney Kimmel Cancer Center at Thomas Jefferson University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider